Skip to main content
. Author manuscript; available in PMC: 2022 Jun 30.
Published in final edited form as: Breast Cancer Res Treat. 2021 Aug 19;190(1):79–88. doi: 10.1007/s10549-021-06361-x

Table 3.

Rates of Adherence Problems in Long-Term per ETMUQ by Group Condition (n=59)

Factor CBT (n=20) Relaxation Training (n=15) Health Education (n=24) Test Statistic p
Forgetfulness/Inconsistency χ2(2) = 6.53 0.04*
Not Endorsed 8 (40.0%) 12 (80.0%) 11 (45.8%)
Endorsed 12 (60.0%) 3 (20.0%) 13 (54.2%)
Intentional Nonadherence χ2(2) = 2.10 0.35
Not Endorsed 13 (65.0%) 13 (86.7%) 18 (75.0%)
Endorsed 7 (35.0%) 2 (13.3%) 6 (25.0%)
Any Adherence Problems χ2(2) = 6.36 0.04*
Not Endorsed 6 (30.0%) 11 (73.3%) 9 (37.5%)
Endorsed 14 (70.0%) 4 (26.7%) 15 (62.5%)

note. ETMUQ= Endocrine Therapy Medication Usage Questionnaire; CBT = Cognitive Behavioral Therapy.

t

p < 1.0,

*

p < .05,

**

p < .01,

***

p < .001